Mediwound Historical Income Statement

MDWD Stock  USD 18.54  0.31  1.70%   
Historical analysis of Mediwound income statement accounts such as Other Operating Expenses of 22.4 M can show how well Mediwound performed in making a profits. Evaluating Mediwound income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mediwound's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Mediwound latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mediwound is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

About Mediwound Income Statement Analysis

Mediwound Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mediwound shareholders. The income statement also shows Mediwound investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Mediwound Income Statement Chart

At present, Mediwound's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 18.2 M, whereas Interest Expense is forecasted to decline to about 466.5 K.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.
Most accounts from Mediwound's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mediwound current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.At present, Mediwound's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 18.2 M, whereas Interest Expense is forecasted to decline to about 466.5 K.
 2022 2023 2024 2025 (projected)
Interest Expense8.9M427K491.1K466.5K
Depreciation And Amortization1.3M1.3M1.5M810.5K

Mediwound income statement Correlations

0.230.530.94-0.07-0.010.840.050.75-0.12-0.15-0.010.050.850.64-0.210.920.69-0.070.120.510.160.95
0.23-0.010.240.06-0.380.38-0.370.26-0.36-0.61-0.340.080.150.11-0.180.290.36-0.3-0.30.13-0.370.23
0.53-0.010.64-0.48-0.460.6-0.430.75-0.51-0.18-0.390.090.240.440.540.360.24-0.4-0.05-0.070.040.33
0.940.240.64-0.35-0.290.92-0.240.92-0.38-0.25-0.280.170.770.560.070.810.55-0.340.10.330.180.86
-0.070.06-0.48-0.350.79-0.420.78-0.620.73-0.060.71-0.250.010.05-0.690.250.510.89-0.270.35-0.420.06
-0.01-0.38-0.46-0.290.79-0.491.0-0.570.890.410.85-0.210.20.12-0.640.190.30.910.260.440.120.15
0.840.380.60.92-0.42-0.49-0.440.88-0.57-0.41-0.470.240.680.450.060.70.45-0.49-0.060.250.070.76
0.05-0.37-0.43-0.240.781.0-0.44-0.530.880.40.85-0.210.250.15-0.650.240.350.910.270.470.130.2
0.750.260.750.92-0.62-0.570.88-0.53-0.64-0.32-0.550.260.540.410.40.570.34-0.590.060.050.160.61
-0.12-0.36-0.51-0.380.730.89-0.570.88-0.640.60.95-0.480.07-0.06-0.610.060.170.770.250.30.140.04
-0.15-0.61-0.18-0.25-0.060.41-0.410.4-0.320.60.6-0.54-0.02-0.01-0.06-0.29-0.420.150.610.110.61-0.1
-0.01-0.34-0.39-0.280.710.85-0.470.85-0.550.950.6-0.650.120.16-0.540.150.240.750.230.460.120.13
0.050.080.090.17-0.25-0.210.24-0.210.26-0.48-0.54-0.650.14-0.310.00.030.0-0.20.03-0.330.070.06
0.850.150.240.770.010.20.680.250.540.07-0.020.120.140.52-0.420.840.630.020.380.640.40.95
0.640.110.440.560.050.120.450.150.41-0.06-0.010.16-0.310.520.040.630.530.110.050.79-0.030.58
-0.21-0.180.540.07-0.69-0.640.06-0.650.4-0.61-0.06-0.540.0-0.420.04-0.35-0.36-0.53-0.15-0.47-0.08-0.41
0.920.290.360.810.250.190.70.240.570.06-0.290.150.030.840.63-0.350.910.19-0.040.58-0.060.93
0.690.360.240.550.510.30.450.350.340.17-0.420.240.00.630.53-0.360.910.4-0.250.48-0.320.72
-0.07-0.3-0.4-0.340.890.91-0.490.91-0.590.770.150.75-0.20.020.11-0.530.190.4-0.140.32-0.260.01
0.12-0.3-0.050.1-0.270.26-0.060.270.060.250.610.230.030.380.05-0.15-0.04-0.25-0.140.270.960.26
0.510.13-0.070.330.350.440.250.470.050.30.110.46-0.330.640.79-0.470.580.480.320.270.150.62
0.16-0.370.040.18-0.420.120.070.130.160.140.610.120.070.4-0.03-0.08-0.06-0.32-0.260.960.150.28
0.950.230.330.860.060.150.760.20.610.04-0.10.130.060.950.58-0.410.930.720.010.260.620.28
Click cells to compare fundamentals

Mediwound Account Relationship Matchups

Mediwound income statement Accounts

202020212022202320242025 (projected)
Depreciation And Amortization1.1M1.2M1.3M1.3M1.5M810.5K
Interest Expense832K903K8.9M427K491.1K466.5K
Selling General Administrative8.7M6.1M8.3M8.6M9.9M7.8M
Other Operating Expenses30.6M35.0M34.8M34.0M39.1M22.4M
Operating Income(8.8M)(11.2M)(8.3M)(15.3M)(13.8M)(14.4M)
Ebit(8.8M)(12.5M)(19.4M)(6.2M)(5.6M)(5.9M)
Research Development7.7M10.3M10.2M7.5M8.6M6.5M
Ebitda(7.8M)(11.2M)(18.1M)(4.9M)(4.4M)(4.6M)
Total Operating Expenses16.4M20.0M21.5M18.9M21.7M15.6M
Income Before Tax(9.3M)(13.5M)(19.5M)(6.5M)(5.9M)(6.2M)
Total Other Income Expense Net(436K)(2.3M)(11.2M)8.8M7.9M8.3M
Net Income(9.6M)(13.6M)(19.6M)(6.7M)(6.0M)(6.3M)
Income Tax Expense325K27K78K185K212.8K223.4K
Cost Of Revenue14.2M15.0M13.3M15.1M17.4M18.2M
Net Income Applicable To Common Shares5.0M(9.2M)(13.6M)(19.6M)(17.6M)(18.5M)
Selling And Marketing Expenses3.2M3.4M2.0M2.8M2.5M3.9M
Total Revenue21.8M23.8M26.5M18.7M21.5M13.1M
Gross Profit7.5M8.8M13.2M3.6M4.1M5.0M
Net Income From Continuing Ops(9.3M)(13.6M)(19.6M)(12.4M)(14.3M)(15.0M)
Interest Income297K11K270K2.3M2.7M2.8M
Net Interest Income(549K)(1.1M)(2.3M)5.9M6.8M7.1M
Reconciled Depreciation1.1M1.2M1.3M1.2M1.4M1.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.91)
Revenue Per Share
2.062
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.15)
Return On Equity
(0.83)
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.